AYALA PHARMACEUTICALS INC (ADXS) Total Assets by Year
AYALA PHARMACEUTICALS INC closed fiscal year 2023 with $16.6M in total assets, $41.0M in total liabilities and -$24.4M in shareholder equity. This represents an increase of 113.4% from the prior fiscal year. The table below carries 15 fiscal years, from 2009 to 2023, and the quarters AYALA PHARMACEUTICALS INC has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ADXS Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K | FY1010-K | FY0910-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.6M+113.4% | $7.8M-83.4% | $46.8M+21.4% | $38.5M-14.9% | $45.3M-27.3% | $62.3M-33.5% | $93.6M-44.6% | $169.0M+41.3% | $119.6M+411.6% | $23.4M-0.9% | $23.6M+518.1% | $3.8M-28.7% | $5.4M+86.3% | $2.9M | N/A |
| Total Liabilities | $41.0M+362.3% | $8.9M+12.4% | $7.9M-5.4% | $8.3M+45.8% | $5.7M-85.0% | $38.2M-3.0% | $39.4M-20.8% | $49.7M+1141.4% | $4.0M+45.8% | $2.7M-50.8% | $5.6M-42.9% | $9.8M-45.4% | $17.9M+1.4% | $17.7M | N/A |
| Total Equity | -$24.4M-2121.7% | -$1.1M-102.8% | $38.9M+28.9% | $30.2M-23.7% | $39.5M+64.4% | $24.1M-55.7% | $54.3M-54.5% | $119.3M+3.2% | $115.6M+460.3% | $20.6M+14.6% | $18.0M+401.9% | -$6.0M+52.5% | -$12.6M+15.1% | -$14.8M+5.9% | -$15.7M |
ADXS Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K | Q3'2210-Q | Q2'2210-Q | Q1'2210-Q | Q4'2110-K | Q3'2110-Q | Q2'2110-Q | Q1'2110-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $16.6M+113.4% | $7.0M-73.1% | $12.2M-59.6% | $21.0M-44.0% | $7.8M-83.4% | $25.9M-49.2% | $30.1M-46.0% | $37.5M-18.3% | $46.8M+21.4% | $51.0M+27.5% | $55.8M+23.4% | $45.9M-10.5% |
| Total Liabilities | $41.0M+362.3% | $13.2M-24.8% | $11.1M-11.3% | $11.3M-10.3% | $8.9M+12.4% | $17.6M+160.8% | $12.6M+52.8% | $12.6M+50.8% | $7.9M-5.4% | $6.7M-21.1% | $8.2M-15.9% | $8.4M-14.6% |
| Total Equity | -$24.4M-2121.7% | -$6.2M-174.9% | $1.0M-94.2% | $9.7M-61.1% | -$1.1M-102.8% | $8.3M-81.2% | $17.5M-63.1% | $24.9M-33.8% | $38.9M+28.9% | $44.3M+40.7% | $47.6M+34.2% | $37.6M-9.6% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More AYALA PHARMACEUTICALS INC financials
Frequently Asked Questions
What was AYALA PHARMACEUTICALS INC's total assets in fiscal year 2023?
AYALA PHARMACEUTICALS INC closed fiscal year 2023 with $16.6M in total assets, $41.0M in total liabilities and -$24.4M in shareholder equity.
How fast is AYALA PHARMACEUTICALS INC's total assets growing?
AYALA PHARMACEUTICALS INC (ADXS) total assets rose by 113.4% year over year, from $7.8M to $16.6M in fiscal year 2023.
What was AYALA PHARMACEUTICALS INC's total assets in the most recent quarter?
AYALA PHARMACEUTICALS INC (ADXS) reported $16.6M in total assets in Q4 2023. This represents an increase of 113.4% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what AYALA PHARMACEUTICALS INC (ADXS) reported on that line in every period on record.